Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
2001
Tyrphostin AG 1024 and Breast Cancer Treatment
publication
Evidence: moderate
Author Information
Author(s): Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim B, Chavaudra N, Bourhis J
Primary Institution: Institut Gustave-Roussy
Hypothesis
Can Tyrphostin AG 1024 enhance radiosensitivity in human breast cancer cells?
Conclusion
Tyrphostin AG 1024 significantly increases the radiosensitivity of breast cancer cells and induces apoptosis.
Supporting Evidence
- Tyrphostin AG 1024 inhibited proliferation and induced apoptosis in a time-dependent manner.
- The degree of growth inhibition for IC20 plus irradiation (4 Gy) was up to 50% compared to the control.
- Tyrphostin AG 1024 enhanced radiosensitivity and amplified radiation-induced apoptosis.
- The study is the first to show that an IGF-1 inhibitor can markedly increase the response of tumor cells to ionizing radiation.
Takeaway
A drug called Tyrphostin AG 1024 helps breast cancer cells respond better to radiation treatment by making them die more easily.
Methodology
The study evaluated the effects of Tyrphostin AG 1024 on proliferation, radiosensitivity, and apoptosis in MCF-7 breast cancer cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website